The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: Results from the Canadian Obstructive Lung Disease (COLD) Study
Open Access
- 1 February 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 16, 305-320
- https://doi.org/10.2147/copd.s285338
Abstract
Purpose: To determine the spirometric-based prevalence of COPD across different regions in Canada and to evaluate the site heterogeneity of risk factors. Patients and Methods: In this cross-sectional, population-based study, random samples of non-institutionalized adults aged ≥ 40 years were generated by random digit dialling. Participants answered an interviewer-administered questionnaire and performed spirometry before and after bronchodilator administration. COPD was defined as post-bronchodilator FEV1/FVC < 0.70 (fixed ratio, FR) and as FEV1/FVC < 5th percentile (lower limits of normal, LLN). Separate logistic regression models were used to compute the risk (adjusted odds ratio, aOR) for COPD. I2 and Tau2 analyses were used to evaluate heterogeneity. Results: Out of 5176 (95%) participants, 4893 (47% male with mean age 56.6 years (95% confidence interval, 56.0– 57.2)) had spirometry that satisfied ATS criteria. The population prevalence of COPD was 16.2% (95% CI, 14.5– 17.8) by FR and 11.2% (95% CI, 9.7– 12.6) by LLN. Male predominance in prevalence was shown by FR but not by LLN criteria. Patient characteristics associated with an increased risk of COPD included: age (OR 1.56; 95% CI 1.33– 1.84); history of physician-diagnosed asthma (OR 3.30; 95% CI 2.42– 4.49); and childhood hospitalization for respiratory illness (OR 1.81; 95% CI 1.17– 2.80). In terms of smoking-related risk factors, current smoking status had the highest odds ratio (OR 3.49; 95% CI 2.55– 4.80). Variance in prevalence among sites was significantly reduced by adjusting for risk factors in Tau2 analyses. Higher odds of exposure for each risk factor was found in more severe COPD, suggesting that a higher risk could be linked to the development of severe disease. Conclusion: This study reports the population prevalence of COPD in nine urban cities which collectively represent the majority of the Canadian population and demonstrates that heterogeneity in prevalence among sites is substantially explained by variation in associated risk factors for COPD.This publication has 39 references indexed in Scilit:
- The prevalence of chronic obstructive pulmonary disease in Maastricht, the NetherlandsRespiratory Medicine, 2012
- The burden of chronic obstructive pulmonary disease among employed adultsInternational Journal of Chronic Obstructive Pulmonary Disease, 2012
- Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD studyEuropean Respiratory Journal, 2009
- Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstructionThorax, 2008
- International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence studyThe Lancet, 2007
- Epidemiology and costs of chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2006
- Standardisation of spirometryEuropean Respiratory Journal, 2005
- Asthma as a Risk Factor for COPD in a Longitudinal StudySocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2004
- Mild prematurity and respiratory functionsEuropean Journal of Pediatrics, 1993
- Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease.BMJ, 1991